84
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Immunogenicity of Influenza Vaccine in Patients with Hemato-Oncological Disorders

&
Pages 369-374 | Received 04 Apr 1998, Published online: 05 Aug 2009

References

  • Hayden G. F., Frayha H., Kattan H., Mogarri I. Structured guidelines for the use of influenza vaccine among children with chronic pulmonary disorders. Pediatr. Infect. Dis. J. 1995; 14: 895–899
  • Honkanen P. O., Keistinen T., Kivela S. L. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 1997; 15 (3): 317–320
  • Nichol K. L., Lind A., Margolis K. L., Murdoch M., McFadden R., Hauge M., Magnan S., Drake M. The effectiveness of vaccination against influenza in healthy, working adults. New England Journal of Medicine 1995; 333: 889–893
  • Nicholson K. G. Socioeconomics of Influenza and Influenza Vaccination in Europe. PharmacoEconomics 1996; 9 (3): 75–78
  • Palache A. M. European Scientific Working Group on Influenza (ESWI). PharmacoEconomics 1996; 9 (3): 1–3
  • Van Hoecke Ch., Prikazsky V., Ütö I., Menschikowski C. Immunogenicity of an Inactivated Split Influenza Vaccine in Institutionalized Elderly Patients. Gerontology 1996; 42: 190–198
  • Ghendon Y. The immune response to influenza vaccines. Acta Virol. 1990; 34: 295–304
  • Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45: 1–22, RR-5
  • Heilman C., LaMontagne J. R. Influenza; status and prospects for its prevention, therapy, control. Pediatr. Clin. NA. 1990; 37: 669–688
  • Blumberg E. A., Albano C., Pruett T., Isaacs R., Fitzpatrick J., Bergin J., Crump C., Hayden F. G. The Immunogenicity of Influenza Virus Vaccine in Solid Organ Transplant Recipients. Clin. Infect. Dis. 1996; 22: 295–302
  • Brydak L. B., Bialek J., Rudnicka H., Denys A., Regnery H., Cox N. Seroconversion Assessment in a Billeted Military Medical University Student Group after Anti-influenza Vaccinations in 1993/1994 in Poland. Antiinfective Drugs and Chemotherapy 1997; 15 (1): 13–16
  • Brydak L. B., Fracka B., Marusak M., Rudnicka H., Nachman S.A. Influenza immunization for children with bronchopulmonary dysplasia in Poland. The Pediatric Infectious Disease Journal 1997; 16 (5): 538–539
  • Brydak L. B., Ordynska E., Wasilewski B., Rudnicka H., Regnery H., Cox N. Immunogenicity of Trivalent Subunit Influenza Vaccine in Elderly People with Chronic Medical Conditions Vaccinated in 1993 in Poland. Antiinfective Drugs and Chemotherapy 1997; 15 (1): 9–12
  • Brydak L. B., Rokicka-Milewska R., Jackowska T., Rudnicka H., Regnery H., Cox N. Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. Leukemia and Lymphoma 1997; 26: 163–169
  • Brydak L. B., Rokicka-Milewska R., Klukowska A., Rudnicka H., Regnery H., Cox N. Antibody kinetics in children with hemophilia immunized with influenza vaccine in 1993 in Poland. Int. J. of Pediatric Hematology/Oncology 1997; 5: 2
  • Brydak L. B., Rokicka-Milewska R., Machala M., Jackowska T., Sikorska-Fic B. Immunogenicity of subunit trivalent purified influenza vaccine in children previously vaccinated or vaccinated for the first time suffering from acute lymphoblastic leukemia. 1998, The Pediatric Infectious Disease Journal (in press)
  • Furth S. L., Neu A. M., McColley S. A., Case B., Steinhoff M., Fivush B. Immune response to influenza vaccination in children with renal disease. Pediatr. Nephrol. 1995; 9: 566–568
  • Glesby M. J., Hoover D. R., Farzadegan H., Margolick J. B., Saah A. J. The Effect of Influenza Vaccination on Human Immunodeficiency virus Type 1 Load: A Randomized, Double-Blind, Placebo-Controlled Study. J. Infect. Dis. 1996; 174: 1332–1336
  • Govaert T. M. E., Sprenger M. J. W., Dinant G. J., Aretz K., Masurel N., Knottnerus J. A. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 1994; 12 (13): 1185–1189
  • Roszkowska-Blaim M., Brydak L., Leszczyńska B., Rudnicka H., Sieniawska M. The efficacy of influenza vaccine in children with renal failure. Pediatria Polska 1997; LXXII (9): 831–834
  • Sorvillo F. J., Nahlen B. L. Influenza immunization for HIV-infected persons in Los Angeles. Vaccine 1995; 13 (4): 377–380
  • Ridgway D., Wolfe L. J. Active immunization of Children with Leukemia and Other Malignancies. Leukemia and Lymphoma 1993; 9: 177–192
  • Aymard-Henry M., Coleman M. T., Dowdle W. R., Laver W. G., Schild G. C., Webster R. G. Influenza virus neuraminidase and neuraminidase-inhibition test procedures. Bull. WHO 1973; 48: 199
  • Douglas A. R. Assay of neuraminidase (NA) activity and neuraminidase inhibition test. Report of the WHO International Collaborative Center for Reference and Research on the Influenza Virus at Mill Hill. NIMR, London 1993
  • Glathe H., Bige S., Grosche A. Comparison of Humoral Immune Response to Trivalent Influenza split Vaccine in Young, Middle-Age and Elderly People. Vaccine 1993; 11: 702–705
  • Hall C. B. Influenza: A Shot or Not?. Pediatrics 1987; 79(4)564–566
  • Honkanen P. O., Keistinen T., Kivela S. L. Factors associated with influenza vaccination coverage among the elderly: role of health care personnel. Public Health 1996; 110: 163–168
  • Nguyen-Van-Tam J. S., Nicholson K. G. Influenza immunization; vaccine offer, request and uptake in high-risk patients during the 1991/2 season. Epidemiol. Inf. 1993; 111(2)347–355
  • Kempe A., Hall C. B., MacDonald N. E., Foye H. R., Woodin K. A., Cohen H. J., Lewis E. D., Gullace M., Gala C. L. Influenza in children with cancer. The Journal of Pediatrics 1989; 115 (1): 33–39
  • Smithson W. A., Siem R. A., Ritts R. E., Gilchrist G. S., Burgert E. O., Ilstrup D. M., Smith T. F. Response to influenza virus vaccine in children receiving chemotherapy for malignancy. The Journal of Pediatrics 1978; 93: 632–634
  • Steinherz P. G., Brown A. E., Gross P. A., Braun D., Ghavimi F., Wollner N., Rosen G., Armstrong D., Miller D. R. Influenza Immunization of Children with Neoplastic Diseases. Cancer 1980; 45 (4): 750–756
  • Sumaya C. V., Williams T. E. Persistance of Antibody After the Administration of Influenza Vaccine to Children with Cancer. Pediatrics 1982; 69(2)226–229
  • Sumaya C. V., Williams T. E., Brunell P. A. Bivalent influenza vaccine in children with cancer. J. Inf. Dis. 1977; 136: S656
  • Beyer W. E. P., Palache A. M., Spreneger M. J. W., Hendriksen E., Tukker J. J., Darioli L., vad der Water G. L., Masurel N., Osterhaus A. D. M. E. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996; 14 (14): 1331–1339
  • Hirota Y., Kaji M., Ide S., Goto S., Oka T. The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age. Vaccine 1996; 14(17/18)1597–1602
  • Künzel W., Glathe H., Engelmann H., Van Hoecke Ch. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine, 14 (12): 1108–1110
  • Rott R., Becht H., Orlich M. The significance of influenza virus neuraminidase in immunity. J. Gen. Virol. 1974; 22: 35–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.